Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 148 for “"Vancomycin"”.

  1. Characterization of Vancomycin Resistance in Staphylococcus Aureus

    … Staphylococcus aureus has developed two distinct vancomycin resistance mechanisms. First, the bacterium is capable of generating a thickened, poorly crosslinked cell wall that creates false targets. These targets cause vancomycin to bind at the periphery of the thickened peptidoglycan, allowing …

    vcu Repository record for Characterization of Vancomycin Resistance in Staphylococcus Aureus (opens in a new tab)

  2. Mechanistic Insights Into Vancomycin Resistance In Clostridioides Difficile

    … become more hypervirulent over the last decade. Vancomycin is currently a frontline antibiotic for the treatment of <em>C. difficile</em> infections. Yet, strains of <em>C. difficile</em> are becoming non-susceptible to vancomycin. Emergence of the vancomycin non-susceptible phenotype has led to …

    uthsc Repository record for Mechanistic Insights Into Vancomycin Resistance In Clostridioides Difficile (opens in a new tab)

  3. Design and synthesis of modified peptide antibiotics of the vancomycin family

    … and S. Aureus that show resistance to vancomycin is an alarming phenomenon, as vancomycin represents the last line of defence against pathogens with a significant level of resistance to all other available therapies, methicillin resistant S. Aureius (MRSA) being a prime example of such …

    whiterose Repository record for Design and synthesis of modified peptide antibiotics of the vancomycin family (opens in a new tab)

  4. Characterization of Metronidazole- and Vancomycin-Resistant Clinical Isolates of Clostridium Difficile

    <p><strong>Characterization of Metronidazole- and Vancomycin-Resistant Clinical Isolates of <em>Clostridium difficile</em></strong></p> <p>Chioma Odo, MS.</p> <p>Supervisory Professor: Charles Darkoh, Ph.D.</p> <p><strong>ABSTRACT</strong></p> <p>The incidence of <em>C. difficile</em> infections …

    uthsc Repository record for Characterization of Metronidazole- and Vancomycin-Resistant Clinical Isolates of Clostridium Difficile (opens in a new tab)

  5. Optimal Control Applied to a Mathematical Model for Vancomycin-Resistant Enterococci

    … be treated effectively with the antibiotic vancomycin are termed Vancomycin-Resistant Enterococci (VRE). In this thesis, we develop a mathematical framework for determining optimal strategies for prevention and treatment of VRE in an Intensive Care Unit (ICU). A system of ve ordinary …

    duquesne Repository record for Optimal Control Applied to a Mathematical Model for Vancomycin-Resistant Enterococci (opens in a new tab)

  6. Rectal culture screening for vancomycin-resistant enterococcus in chronic haemodialysis patients

    Infection or colonisation with vancomycin-resistant enterococci (VRE) is common in chronic haemodialysis(HD) patients. However, there is limited information on the duration of VRE colonisation or on the reliability of consecutive negative rectal cultures to determine the clearance of VRE in chronic …

    ajou Repository record for Rectal culture screening for vancomycin-resistant enterococcus in chronic haemodialysis patients (opens in a new tab)

  7. Molecular Characterization of Vancomycin-resistant Enterococci from Clinical and Surveillance Specimens

    BACKGROUND: Vancomycin-resistant enterococci(VRE) were first detected in Europe in 1986, and have been isolated from hospitalized patients worldwide. VanA resistance, characterized by high level resistance to vancomycin and teicoplanin, is the most prevalent in clinical enterococcal isolates. To …

    ajou Repository record for Molecular Characterization of Vancomycin-resistant Enterococci from Clinical and Surveillance Specimens (opens in a new tab)

  8. Repurposing Antibacterial Compounds and Natural Products to Combat Vancomycin-Resistant Enterococci

    … Among the most concerning pathogens are vancomycin-resistant Enterococcus (VRE), which causes serious bloodstream, urinary tract, and wound infections, particularly in hospitalized patients. This thesis explores two complementary strategies to address this challenge: natural product …

    vt Repository record for Repurposing Antibacterial Compounds and Natural Products to Combat Vancomycin-Resistant Enterococci (opens in a new tab)

  9. Detection of Vancomycin resistant Enterococci from clinical specimens at University Teaching Hospitals

    … to glycopeptide antibiotics, especially Vancomycin is of special concern as Vancomycin resistant genes are encoded on plasmids which can be transferred to other organisms. Currently, there is no documented information relating to the occurrence and resistance genes of VRE at the …

    zimbabwe Repository record for Detection of Vancomycin resistant Enterococci from clinical specimens at University Teaching Hospitals (opens in a new tab)

  10. Detection of Vancomycin resistant Enterococci from clinical specimens at University Teaching Hospitals

    … to glycopeptide antibiotics, especially Vancomycin is of special concern as Vancomycin resistant genes are encoded on plasmids which can be transferred to other organisms. Currently, there is no documented information relating to the occurrence and resistance genes of VRE at the …

    zambia Repository record for Detection of Vancomycin resistant Enterococci from clinical specimens at University Teaching Hospitals (opens in a new tab)

  11. Development of dissolving and hydrogel-forming microneedles for delivery of vancomycin hydrochloride

    … deadly infections, including neonatal sepsis. Vancomycin, a glycopeptide antibiotic, remains the most effective antibiotic to treat this condition. In the case of systemic diseases, vancomycin must be administered via intravenous injection. However, administration of vancomycin via this route …

    qu-belfast Repository record for Development of dissolving and hydrogel-forming microneedles for delivery of vancomycin hydrochloride (opens in a new tab)

  12. I. Transannular Sulfoxide - Ketone Interaction. Ii. A Prospectus of the Vancomycin Structure

    Made available in DSpace on 2014-12-05T19:38:02Z (GMT). No. of bitstreams: 1 6206166.pdf: 4399515 bytes, checksum: c7ff8da0afe1b70c28dc46e03a1d12fa (MD5) Previous issue date: 1962

    uiuc Repository record for I. Transannular Sulfoxide - Ketone Interaction. Ii. A Prospectus of the Vancomycin Structure (opens in a new tab)

  13. Library Screening and Focused Multiomics of Antibacterial Action on Vancomycin-Resistant Enterococci faecium

    … the gastrointestinal tract and the soft tissues. Vancomycin has been one of most important agents for the treatment of gram-positive bacterial infections. The emergence and spread of vancomycin resistance has become a serious public health issue and vancomycin resistant bacteria are world’s …

    umkc Repository record for Library Screening and Focused Multiomics of Antibacterial Action on Vancomycin-Resistant Enterococci faecium (opens in a new tab)

  14. Some Properties of Vancomycin in Relation to Its Absorption and Movement in Plants

    Made available in DSpace on 2014-12-05T20:30:08Z (GMT). No. of bitstreams: 1 0025253.pdf: 4409449 bytes, checksum: 836c6c5a9f4305486875560d04a18dd9 (MD5) Previous issue date: 1957

    uiuc Repository record for Some Properties of Vancomycin in Relation to Its Absorption and Movement in Plants (opens in a new tab)

  15. A genome wide approach to identify factors asociated with vancomycin non-susceptibility in Staphylococus aureus

    Vancomycin (VAN) represents the standard of care in the treatment of Methicillin-Resistant S. aureus (MRSA) infections and widespread use has driven antimicrobial resistance. While fully resistant S. aureus strains have been identified, vancomycin-intermediate S. aureus (VISA) and heterogeneous …

    tdl Repository record for A genome wide approach to identify factors asociated with vancomycin non-susceptibility in Staphylococus aureus (opens in a new tab)

  16. A genome wide approach to identify factors asociated with vancomycin non-susceptibility in Staphylococus aureus

    Vancomycin (VAN) represents the standard of care in the treatment of Methicillin-Resistant S. aureus (MRSA) infections and widespread use has driven antimicrobial resistance. While fully resistant S. aureus strains have been identified, vancomycin-intermediate S. aureus (VISA) and heterogeneous …

    texas Repository record for A genome wide approach to identify factors asociated with vancomycin non-susceptibility in Staphylococus aureus (opens in a new tab)

Page 1 of 8